A decreasing trend in NKT cell migration was observed in the sh-TACC2 group; however, the difference did not reach statistical significance (Supplementary Fig. 8 D).
← all excerpts
Loss of TACC2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma.
1
—
—